Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed Clinical Research is a complete, global Phase I-IV clinical development and trial management service with a strong heritage in the development of drugs in rare diseases and oncology.